X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Cadila Healthcare Fact Sheet, Cadila Healthcare Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Cadila Healthcare Fact Sheet   (CADIL)

Here is the latest financial fact sheet of Cadila Healthcare. For more details, see the Cadila Healthcare quarterly results and Cadila Healthcare share price and chart. For a sector overview, read our pharmaceuticals sector report.

CADILA HEALTHCARE Price History

Price Rs 448.1
Mkt Cap Rs m 458,687
Vol '000 89.2
P/E X 33.3
P/CF X 24.7
EPS (TTM) Rs 13.5
% ch % 0.4
No. of shares m 1,023.74
% ch week % -0.1
% ch 1-mth % -8.8
% ch 12-mth % 22.7
52 week H/L Rs 558.0/330.0
(As on Nov 21, 2017 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

CADILA HEALTHCARE Financials

No. of Mths
Year Ending
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
5-Yr Chart
Click to enlarge
CADILA HEALTHCARE EQUITY SHARE DATA
High Rs9641,0791,763454460 
Low Rs695631872305305 
Sales per share (Unadj.) Rs310.5352.8422.592.192.1 
Earnings per share (Unadj.) Rs31.939.256.219.214.8 
Diluted earnings per shareRs6.47.811.219.214.8 
Cash flow per share (Unadj.) Rs40.949.170.222.018.5 
Dividends per share (Unadj.) Rs7.509.0012.003.203.20 
Adj. dividends per shareRs1.501.802.403.203.20 
Dividend yield (eoy) %0.91.10.90.80.8 
Book value per share (Unadj.) Rs143.8168.0220.855.768.0 
Adj. book value per shareRs28.833.644.255.768.0 
Shares outstanding (eoy) m204.75204.75204.751,023.741,023.74 
Bonus/Rights/Conversions  ---FV5:1- 
Price / Sales ratio x2.72.43.14.14.2 
Avg P/E ratio x26.021.823.419.825.8 
P/CF ratio (eoy) x20.317.418.817.220.7 
Price / Book Value ratio x5.85.16.06.85.6 
Dividend payout %23.522.921.416.721.6 
Avg Mkt Cap Rs m169,840175,061269,758388,458391,581 
No. of employees `00012.212.213.215.416.9 
Total wages/salary Rs m9,04210,71112,08512,61615,002 
Avg. sales/employee Rs Th5,214.65,908.26,564.06,105.05,594.5 
Avg. wages/employee Rs Th741.6876.0916.9817.0890.1 
Avg. net profit/employee Rs Th536.0657.2873.01,272.1899.9 
CADILA HEALTHCARE INCOME DATA
Net Sales Rs m63,57772,24086,51394,26894,295 
Other income Rs m3705075541,1561,286 
Total revenues Rs m63,94772,74787,06795,42495,581 
Gross profit Rs m11,25112,00117,59923,30519,036 
Depreciation Rs m1,8472,0122,8732,9213,750 
Interest Rs m1,687902679528450 
Profit before tax Rs m8,0879,59414,60121,01216,122 
Minority Interest Rs m-364-326-397430338 
Prior Period Items Rs m-132654200 
Extraordinary Inc (Exp) Rs m0-172-104-25-3 
Tax Rs m1,1751,3252,6361,7741,289 
Profit after tax Rs m6,5358,03611,50619,64315,168 
Gross profit margin %17.716.620.324.720.2 
Effective tax rate %14.513.818.18.48.0 
Net profit margin %10.311.113.320.816.1 
CADILA HEALTHCARE BALANCE SHEET DATA
Current assets Rs m31,91734,37940,88742,80460,223 
Current liabilities Rs m26,70428,14029,92134,61053,058 
Net working cap to sales %8.28.612.78.77.6 
Current ratio x1.21.21.41.21.1 
Inventory Days Days7069605270 
Debtors Days Days5557696888 
Net fixed assets Rs m37,61240,15340,52646,98772,984 
Share capital Rs m1,0241,0241,0241,0241,024 
"Free" reserves Rs m23,82627,84544,18455,96868,576 
Net worth Rs m29,44534,39045,20856,99269,600 
Long term debt Rs m14,26013,62211,5048,96424,684 
Total assets Rs m73,74279,86591,342105,506152,207 
Interest coverage x5.811.622.540.836.8 
Debt to equity ratio x0.50.40.30.20.4 
Sales to assets ratio x0.90.90.90.90.6 
Return on assets %11.111.213.319.110.3 
Return on equity %22.223.425.534.521.8 
Return on capital %21.521.426.133.317.9 
Exports to sales %24.327.732.547.20 
Imports to sales %6.45.86.26.20 
Exports (fob) Rs m15,44220,03828,08044,5370 
Imports (cif) Rs m4,0734,2105,3915,8380 
Fx inflow Rs m16,23620,61329,66644,88121,280 
Fx outflow Rs m6,6206,8648,0939,06910,874 
Net fx Rs m9,61613,74921,57335,81210,406 
CADILA HEALTHCARE CASH FLOW
From Operations Rs m 6,034 9,028 9,936 18,935 13,495 
From Investments Rs m -6,823 -4,380 -4,647 -8,635 -29,103 
From Financial Activity Rs m 2,858 -5,287 -3,511 -9,348 23,158 
Net Cashflow Rs m 2,069 -639 1,778 991 7,556 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.8%
Foreign collaborators 0.0%
Indian inst/Mut Fund 8.3%
FIIs 5.9%
ADR/GDR 0.0%
Free float 11.0%
Shareholders 44,069
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Zydus Tower, Satellite Cross Roads, Ahmedabad - 380 015
E-MAIL upen.shah@zyduscadila.com WEB www.zyduscadila.com
TELEPHONE (079) 2686 8326 FAX (079) 2686 2365
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Sharepro Serv.,416-420, Devnandan Mall, Ellisbridge, Ahmedabad-09
AUDITOR Mukesh M. Shah & Co.
CHM: Pankaj R. Patel (MD) COMP SEC: Upen H. Shah YEAR OF INC: 1995 BSE CODE: 532321 FV (Rs): 5 DIV YIELD (%): 0.7

More Pharmaceuticals Company Fact Sheets:   TORRENT PHARMA  SANOFI INDIA  LUPIN LTD  WOCKHARDT LTD.  PLETHICO PHARMA  

Compare CADILA HEALTHCARE With:   TORRENT PHARMA  SANOFI INDIA  LUPIN LTD  WOCKHARDT LTD.  PLETHICO PHARMA  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Strong, Logistics Sector Gets Infra Push, and Top Stocks in Action(Pre-Open)

On Tuesday, share markets in India opened in green and traded positively throughout the day and ended the day strong.

Views on news

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

'Buy and Hold Forever' Not The Best Investing Style After All(The 5 Minute Wrapup)

Nov 9, 2017

Even Buffett didn't always Buy and Hold forever. A look at Berkshire's 1992 and 2017 portfolios will tell you the story...

Of Falling Real Estate Prices, Dr Arvind Panagariya and the Art of Continuing to Suck Up(Vivek Kaul's Diary)

Nov 13, 2017

Dr Panagariya claims real estate prices have fallen 25 per cent post demonetisation; the official data doesn't show anything like that.

Your Last Chance to Trade ONLY the Best Stocks(Daily Profit Hunter)

Nov 11, 2017

Techno-Funda opportunities are knocking on your door. Are you ready to receive them?

Why I am the Biggest India Equity Bull on Planet Earth!(The Honest Truth)

Nov 16, 2017

If you have a dream, dream big...about the level of BSE 30 index in 2050!

The Day Warren Buffett Lost All His Money(Smart Contrarian)

Nov 15, 2017

Buffett is still using the lessons he learnt that fateful day.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - GLENMARK PHARMA COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS